NSC 224249 is an effective dual inhibitor of human CYP17A1 and 5alpha-reductase that effectively blocks the androgen synthesis pathway. It can be used to treat androgen-dependent diseases such as prostate cancer and for research into the regulation of steroid hormone metabolism.
Molecular Weight:
371.51
Purity:
99.42%
CAS Number:
[2174-13-2]
Formula:
C23H33NO3
Target:
Reductase
T212764
* VAT and and shipping costs not included. Errors and price changes excepted
